<DOC>
	<DOC>NCT00874484</DOC>
	<brief_summary>The investigators hypothesize that injections of Low molecular weight heparin (LMWH) [enoxaparin] will reduce pain in women with vulvodynia.</brief_summary>
	<brief_title>Enoxaparin as Treatment for Vulvodynia</brief_title>
	<detailed_description />
	<mesh_term>Vulvodynia</mesh_term>
	<criteria>women with vulvodynia women without vulvodynia</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>